• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃食管交界腺癌根治性切除术后的复发危险因素及模式

Risk factors and patterns of recurrence after curative resection in Gastroesophageal Junction Adenocarcinoma.

作者信息

Batool Sadaf, Khan Misbah, Akbar Sana Amir, Ashraf Ijaz

机构信息

Sadaf Batool, MRCS. FCPS Trainee, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.

Misbah Khan, FCPS. Fellow European Board of Surgical Oncology, Fellow Surgical Oncology, Senior Instructor Surgical Oncology, Shaukat Khanum Memorial Cancer Hospital, MRCS. Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.

出版信息

Pak J Med Sci. 2019 Sep-Oct;35(5):1276-1283. doi: 10.12669/pjms.35.5.963.

DOI:10.12669/pjms.35.5.963
PMID:31488992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6717491/
Abstract

OBJECTIVES

We looked at risk factors and patterns of recurrence following surgical treatment of Gastro-Oesophageal Junction carcinoma (GOJC).

METHODS

Electronic medical records of patients with GOJC undergoing resection with curative intent between Jan 2009 and June 2017 at Shaukat Khanum Memorial Cancer Hospital were reviewed. GOJ cancer was classified as per Siewert classification. Clinical and operative details were studied and data was analysed using SPSS 20.

RESULTS

During the study period, we identified 78 patients with GOJ adenocarcinoma (38 patients with GOJ Type-I, 16 with Type-II tumors and 24 patients with GOJ Type-III tumors). Median age was 56 years ± 1.1. Male to female distribution was 72 versus 28%. Carbo-Pacli /5-FU based XRT verses Magic protocol (p<0.015) and advanced pathological T.-stage (p-value<0.032) were found to be statistically significant risk factors for recurrence. After a median follow up of 17.8 months+/- 1.5, 20 patients developed recurrence of which five had local recurrence, three had regional recurrence, eight had distant metastases and four had both local and distant metastases.

CONCLUSION

The incidence of recurrence following curative resection of GOJC is 25%. Type of neoadjuvant treatment, waiting time for surgery and advanced T-stage are a risk factor for recurrence.

摘要

目的

我们研究了胃食管交界癌(GOJC)手术治疗后的危险因素及复发模式。

方法

回顾了2009年1月至2017年6月在沙卡特汗姆纪念癌症医院接受根治性切除的GOJC患者的电子病历。GOJ癌根据Siewert分类法进行分类。研究临床和手术细节,并使用SPSS 20分析数据。

结果

在研究期间,我们确定了78例GOJ腺癌患者(38例GOJ I型患者,16例II型肿瘤患者和24例GOJ III型肿瘤患者)。中位年龄为56岁±1.1。男女分布为72%对28%。发现基于卡铂-紫杉醇/5-氟尿嘧啶的放疗方案与Magic方案(p<0.015)以及晚期病理T分期(p值<0.032)是具有统计学意义的复发危险因素。中位随访17.8个月±1.5后,20例患者出现复发,其中5例为局部复发,3例为区域复发,8例为远处转移,4例为局部和远处转移。

结论

GOJC根治性切除术后的复发率为25%。新辅助治疗类型、手术等待时间和晚期T分期是复发的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59df/6717491/7baa253fc270/PJMS-35-1276-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59df/6717491/9f2cbda63c32/PJMS-35-1276-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59df/6717491/7baa253fc270/PJMS-35-1276-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59df/6717491/9f2cbda63c32/PJMS-35-1276-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59df/6717491/7baa253fc270/PJMS-35-1276-g002.jpg

相似文献

1
Risk factors and patterns of recurrence after curative resection in Gastroesophageal Junction Adenocarcinoma.胃食管交界腺癌根治性切除术后的复发危险因素及模式
Pak J Med Sci. 2019 Sep-Oct;35(5):1276-1283. doi: 10.12669/pjms.35.5.963.
2
Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers.癌症患者的癌症治疗和生存的地理差异:食管和胃食管交界处癌症。
Br J Surg. 2020 Oct;107(11):1500-1509. doi: 10.1002/bjs.11671. Epub 2020 Jun 2.
3
The postoperative component of MAGIC chemotherapy is associated with improved prognosis following surgical resection in gastric and gastrooesophageal junction adenocarcinomas.MAGIC化疗的术后部分与胃和胃食管交界腺癌手术切除后的预后改善相关。
Int J Surg Oncol. 2013;2013:781742. doi: 10.1155/2013/781742. Epub 2013 Sep 17.
4
The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction.食管胃结合部腺癌的多模态治疗时代中 Siewert 分类的相关性。
J Surg Oncol. 2014 Mar;109(3):202-7. doi: 10.1002/jso.23484. Epub 2013 Nov 14.
5
Recurrence following curative intended surgery for an adenocarcinoma in the gastroesophageal junction: a retrospective study.胃食管交界腺癌根治性手术后的复发:一项回顾性研究。
Dis Esophagus. 2018 Apr 1;31(4). doi: 10.1093/dote/dox136.
6
Risk factors effecting development of metachronous liver metastasis in rectal cancer patients after curative surgical resection. Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore experience.影响直肠癌患者根治性手术切除后异时性肝转移发生的危险因素。拉合尔绍卡特·汗姆纪念癌症医院及研究中心的经验。
J Pak Med Assoc. 2019 Feb;69(2):201-204.
7
[Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].新辅助放化疗联合手术与直接手术治疗食管胃交界部SiewertⅡ型和Ⅲ型腺癌:一项前瞻性随机对照试验的长期预后分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Feb 25;24(2):128-137. doi: 10.3760/cma.j.cn.441530-20201019-00565.
8
[Risk factors of early recurrence and prognosis for patients with adenocarcinoma of gastroesophageal junction after curative resection].[胃食管交界腺癌根治性切除术后患者早期复发及预后的危险因素]
Zhonghua Yi Xue Za Zhi. 2013 Dec 3;93(45):3594-7.
9
Patterns of care and outcomes for gastric and gastro-oesophageal junction cancer in an Australian population.澳大利亚人群中胃癌和胃食管交界癌的治疗模式与结局
ANZ J Surg. 2021 Dec;91(12):2675-2682. doi: 10.1111/ans.17249. Epub 2021 Oct 7.
10
The clinicopathologic characteristics and prognostic factors of gastroesophageal junction tumors according to Siewert classification.根据Siewert分类法的胃食管交界部肿瘤的临床病理特征及预后因素
Turk J Surg. 2017 Mar 1;33(1):18-24. doi: 10.5152/UCD.2017.3379. eCollection 2017.

引用本文的文献

1
Treatment of Anastomotic Recurrence After Esophagectomy.食管切除术后吻合口复发的治疗。
Ann Thorac Surg. 2022 Aug;114(2):418-425. doi: 10.1016/j.athoracsur.2021.07.101. Epub 2021 Sep 10.
2
Can we predict mediastinal lymph nodes metastasis in esophagogastric junction cancer? Results of a systematic review and meta-analysis.我们能否预测食管胃交界癌的纵隔淋巴结转移?一项系统评价和荟萃分析的结果。
Gen Thorac Cardiovasc Surg. 2021 Aug;69(8):1165-1173. doi: 10.1007/s11748-021-01665-7. Epub 2021 Jun 9.

本文引用的文献

1
Global Cancer Incidence and Mortality Rates and Trends--An Update.全球癌症发病率、死亡率及趋势——最新情况
Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):16-27. doi: 10.1158/1055-9965.EPI-15-0578. Epub 2015 Dec 14.
2
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.新辅助放化疗联合手术与单纯手术治疗食管或食管胃交界癌(CROSS):一项随机对照临床试验的长期结果。
Lancet Oncol. 2015 Sep;16(9):1090-1098. doi: 10.1016/S1470-2045(15)00040-6. Epub 2015 Aug 5.
3
Global cancer statistics, 2012.
全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
4
Recurrence patterns of esophagogastric junction adenocarcinoma according to Siewert's classification after radical resection.根治性切除术后根据 Siewert 分类的食管胃结合部腺癌的复发模式。
Anticancer Res. 2014 Aug;34(8):4391-7.
5
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials.CROSS 试验中单手术治疗与术前放化疗加手术治疗后的复发模式。
J Clin Oncol. 2014 Feb 10;32(5):385-91. doi: 10.1200/JCO.2013.51.2186. Epub 2014 Jan 13.
6
Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China.胃食管结合部腺癌:一家中国单中心经验。
World J Surg Oncol. 2013 Jul 13;11:155. doi: 10.1186/1477-7819-11-155.
7
Diagnosis and treatment of non-metastatic esophagogastric junction adenocarcinoma: what are the current options?非转移性食管胃结合部腺癌的诊断与治疗:当前有哪些选择?
J Visc Surg. 2012 Feb;149(1):e23-33. doi: 10.1016/j.jviscsurg.2012.01.003. Epub 2012 Feb 16.
8
Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.可切除胃食管腺癌的围手术期化疗与单纯手术比较:FNCLCC 和 FFCD 多中心 III 期试验。
J Clin Oncol. 2011 May 1;29(13):1715-21. doi: 10.1200/JCO.2010.33.0597. Epub 2011 Mar 28.
9
The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.美国癌症联合委员会:第 7 版 AJCC 癌症分期手册与 TNM 的未来。
Ann Surg Oncol. 2010 Jun;17(6):1471-4. doi: 10.1245/s10434-010-0985-4.
10
Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan.台湾的 Siewert 分类食管胃结合部腺癌。
Ann Surg Oncol. 2009 Dec;16(12):3237-44. doi: 10.1245/s10434-009-0636-9.